Parent Page: Academic Departments id: 21552 Active Page: Research Faculty Profilesid:21580


Jordan Neil, PhD
Family and Preventive Medicine

Jordan Neil, PhD

Assistant Professor

Health Promotion Research Center
University of Oklahoma Health Sciences Center
655 Research Parkway, Suite 400
Oklahoma City, OK  73104


(405) 271-6872

Dr. Jordan Neil specializes in translational cancer communication science, which uses communication-centered strategies to translate evidence-based cancer prevention behaviors into practice among communities. His research focuses on how to improve uptake of tobacco cessation services and colorectal and lung cancer screening, as well as participation rates in cancer clinical trials. To do so, Dr. Neil leverages mixed methods and adaptive trial designs to develop, evaluate, and optimize digital interventions, with particular interest in disseminating tailored navigation strategies to meet the needs of rural and underserved patient populations.

Academic Section(s):

OUFMC Research Division


2018 - 2021
Harvard Medical School/Massachusetts General Hospital, Boston, MA.
Postdoctoral Research Fellow
Mongan Institute Health Policy Research Center, Department of Medicine
Qualitative and Mixed Methods Research Unit, Division of Clinical Research

2017 - Ph. D.
University of Florida, Gainesville, FL.
Doctor of Philosophy with a major in Mass Communication; Specialization:
Translational Cancer Communication
College of Journalism and Communications

2011 - M.A.
East Carolina University, Greenville, NC.
Master of the Arts in Communication; Specialization: Health Communication
School of Communication

2010 - B.Sc.
McNeese State University, Lake Charles, LA.
Bachelor of Science in Mass Communication; Specialization: Journalism
Department of Mass Communication

Clinical/Research Interests:

  • His research focuses on how to improve uptake of tobacco cessation services and colorectal and lung cancer screening, as well as participation rates in cancer clinical trials.



Stephenson Cancer Center Pilot Grant Program
A pilot randomized controlled trial to determine feasibility and potential efficacy of COLOCARE.
Award period: 05/01/2021 – 04/30/2022
Role: Principal Investigator

MGH Radiology Thrall Grant
A community-based participatory approach to understand the effect of COVID-19 on Asian American women’s intentions receive a COVID-19 vaccine and screen for cancer.
Award period:
Role: Multiple Principal Investigator

R01: Special Applications for Health Services and Delivery Study Section
Assessing the integration of tobacco cessation treatment into lung cancer screening.
NIH, National Cancer Institute.
Award Period: 04/01/2018 – 03/31/2023
MPIs: Park, Elyse; Haas, Jennifer; Rigotti, Nancy.
Role: Postdoctoral Fellow

R01: Behavioral and Social Science Research on Understanding and Reducing Health Disparities
NIH, National Cancer Institute
A patient-centered intervention using virtual technology to reduce colorectal cancer disparities in primary care.
Award Period: 02/01/2017 – 01/31/2022
PI: Krieger, Janice.
Role: Consultant

MGH Primary Care Innovation Fund
Developing a proof of concept mobile health navigator for current smokers to complete LUng and ColorectAl Screening (LUCAS).
Award period: 02/01/2020 – 06/30/2021
Role: Principal Investigator

National Institute of Health Diversity Supplement
Assessing the integration of tobacco cessation treatment into lung cancer screening
Award Period: 06/01/2019 -  06/01/2021
PI: Flores, Efren.
Role: Mentor

MGH Department of Medicine Transformative Scholars Award
Engagement with an adaptive mobile health smoking cessation intervention.
Award Period: 04/01/2019 – 03/31/2021
PI: Kruse, Gina.
Role: Co-Investigator

Select Publications:

  • Neil JM, Senecal C, Ballini L, Chang Y, Goshe B, Flores E, et al. A multimethod evaluation of tobacco treatment trial recruitment messages for current smokers recently diagnosed with cancer: Pilot factorial randomized controlled trial. JMIR Cancer 2022; 8(3):e37526.  DOI: 10.2196/37526
  • Vilaro MJ, Wilson-Howard DS, Neil JM, et al. A subjective culture approach to cancer prevention: rural Black and White adults' perceptions of using virtual health assistants to promote colorectal cancer screening. Health Communication. August 2022; 37(9):1123-1134.   DOI: 10.1080/10410236.2021.1910166
  • Goshe BM, Rasmussen AW, Wagner LI, Sicks JD, Gareen IF, Carlos RC, Herman BA, Walter AW, Regan S, Levy DE, Mahan I, Muzikansky A, Neil JM, et al. Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]. BMC Public Health 2022; 22(1): 1359.  DOI: 10.1186/s12889-022-13631-w
  • Cooks EJ, Duke KA, Neil JM, Vilaro MJ, Wilson-Howard D, Modave F, et al. Telehealth and racial disparities in colorectal cancer screening: A pilot study of how virtual clinician characteristics influence screening intentions. Journal of Clinical and Translational Science 2022; 6(1): e48. DOI: 10.1017/cts.2022.386
  • Benson L, Ra CK, Hebert ET, Kendzor DE, Oliver JA, Frank-Pearce SG, Neil JM, Businelle MS. Quit stage and intervention type differences in the momentary within-person association between negative affect and smoking urges. Frontiers in Digital Health 2022; 4: 864003. DOI: 10.3389/fdgth.2022.864003
  • Neil JM, Parker ND, Levites Strekalova YA, Duke K, George T, Krieger JL. Communicating risk to promote colorectal cancer screening: a multi-method study to test tailored versus targeted message strategies. Health Education Research 2022; 37(2):79-93. DOI: 10.1093/her/cyac002
  • Streck JM, Regan S, Neil J, Kalkhoran S, Gupta PS, Bearnot B, et al. Interest in electronic cigarettes for smoking cessation among adults with OUD in buprenorphine treatment: a mixed-methods investigation. Nicotine & Tobacco Research 2021. DOI: 10.1093/ntr/ntab259
  • Flores EJ, Neil JM, Tiersma KM, et al. Feasibility and acceptability of a collaborative lung cancer screening educational intervention tailored for individuals with serious mental illness. Journal of the American College of Radiology. December 2021; 18(12): 1624-1634.  DOI: 10.1016/j.jacr.2021.07.010
  • Eyestone E, Williams RM, Luta G, Kim E, Toll BA, Rojewski A, Neil J, Cinciripini PM, et al. Predictors of enrollment of older smokers in six smoking cessation trials in the lung cancer screening setting: the Smoking Cessation At Lung Examination (SCALE) collaboration. Nicotine & Tobacco Research. December 2021; 23(12): 2037-2046.   DOI: 10.1093/ntr/ntab110
  • Wilson-Howard D, Vilaro MJ, Neil JM, Cooks EJ, et al. The development of a credible virtual clinician promoting colorectal cancer screening via telehealth applications for and by Black men: a qualitative study. JMIR Formative Research. Dec. 2021.  DOI: 10.2196/28709
  • Neil JM, Marotta C, Gonzales I, Chang Y, Levy DE, Wint A, Harris K, Hawari S, Noonan E, Styklunas G, Crute S, Howard SE, Sheppard J, Lennes IT, Jacobson F, Flores E, Haas JS, Park ER, Rigotti NA. Integrating tobacco treatment into lung cancer screening practices: Study protocol for the Screen ASSIST randomized clinical trial. Contemporary Clinical Trials. October 2021; 111:106586.    DOI: 10.1016/j.cct.2021.106586
  • Krieger JL, Neil JM, Duke KA, et al. A pilot study examining the efficacy of delivering colorectal cancer screening messages via virtual health assistants. American Journal of Preventive Medicine.  August 2021;61(2):251-255.   DOI: 10.1016/j.amepre.2021.01.014
  • Zalake M. Tavassoli F, Duke K, George T, Modave F, Neil J, Kreiger J, Lok B. Internet-based tailored virtual human health intervention to promote colorectal cancer screening: design guidelines from two user studies. Journal on Multimodal User Interfaces. June 2021; 15(2):147-162.  DOI: 10.1007/s12193-020-00357-5
  • Neil JM, Chang Y, Goshe B, et al. A web-based intervention to increase smokers’ intentions to participate in a cessation study offered at the point of lung screening: factorial randomized trial. JMIR Formative Research. June 2021;5(6): e28952.   DOI: 10.2196/28952
  • Hall DL, Neil JM, Ostroff JS, Hawari S, O'Cleirigh C, Park ER. Perceived cancer-related benefits of quitting smoking and associations with quit intentions among recently diagnosed cancer patients. Journal of Health Psychology. May 2021;26(6):831-842.  DOI: 10.1177/1359105319845131
  • Algarin AB, Zhou Z, Canidate S, Gebru NM, Kreiger JL, Neil JM, et al. PrEP awareness among people living with HIV in Florida: Florida Cohort study. AIDS Care. April 2021;33(4):428-433.  DOI: 10.1080/09540121.2020.1717421
  • Kalkhoran S, Kalagher KM, Neil JM, Rigotti NA. Cigarette and e-cigarette use among smokers after a statewide e-cigarette sales ban. Tobacco Regulatory Science. March 2021;7(2):135-143.  DOI 10.18001/Trs.7.2.5
  • Wang GX, Neil JM, Fintelmann FJ, Little BP, Narayan AK, Flores EJ. Guideline-discordant lung cancer screening: emerging demand and provided indications. Journal of the American College of Radiology. March 2021;18(3 Pt A):395-405.  DOI: 10.1016/j.jacr.2020.08.005
  • Joyce AA, Styklunas GM, Rigotti NA, Neil JM, Park ER, Kruse GR. Quit experiences among primary care patients enrolled in a smoking cessation pilot RCT early in the COVID-19 pandemic. International Journal of Environmental Research and Public Health. January 2021;18(3):1011. DOI: 10.3390/ijerph18031011